G Medical Innovations Stock (NASDAQ:GMVD)


OwnershipChart

Previous Close

$0.18

52W Range

$0.14 - $13.82

50D Avg

$0.30

200D Avg

$1.78

Market Cap

$1.80M

Avg Vol (3M)

$1.24M

Beta

-1.08

Div Yield

-

GMVD Company Profile


G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

84

IPO Date

Jun 25, 2021

Website

GMVD Performance


Peer Comparison


TickerCompany
FEMYFemasys Inc.
ZJYLJin Medical International Ltd.
AKYAAkoya Biosciences, Inc.
GCTKGlucoTrack, Inc.
ATRIAtrion Corporation
MBOTMicrobot Medical Inc.
MHUAMeihua International Medical Technologies Co., Ltd.
POAIPredictive Oncology Inc.
LUCYInnovative Eyewear, Inc.
PDEXPro-Dex, Inc.
NXGLNEXGEL, Inc.
STSSSharps Technology, Inc.